Drawing for KINVITRAR

USPTO serial 79185130

KINVITRAR

Reviewed by CopyMark Law Group

Reg. 5038603Status 404
Filing date
Status date
Registration date
Sep 13, 2016
Examiner
PAQUIN, SAMUEL ROBERT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KINVITRAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; biological preparations and stem cells for pharmaceutical and medical purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 27, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Jan 21, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Dec 28, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Dec 28, 2023INPCINVALIDATION PROCESSED—
Nov 24, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 24, 2023C71TCANCELLED SECTION 71—
Sep 13, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 9, 2017OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 24, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 2, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 2, 2017FIMPFINAL DISPOSITION PROCESSED—
Dec 13, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 13, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 28, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 28, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 8, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 8, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 8, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 27, 2016RFNPREFUSAL PROCESSED BY IB—
May 26, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 25, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 25, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 25, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 17, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 17, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 9, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 9, 2016RFRRREFUSAL PROCESSED BY MPU—
May 7, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 6, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2016DOCKASSIGNED TO EXAMINER—
Apr 1, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 28, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 25, 2016LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Mar 24, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance